Anika Therapeutics (ANIK) Goodwill (2010 - 2026)

Anika Therapeutics (ANIK) has 17 years of Goodwill data on file, last reported at $7.9 million in Q1 2026.

• Goodwill for Q1 2026 came in at $7.9 million, up 6.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.9 million (up 6.32% YoY), and the FY2025 annual result was $8.1 million, up 13.04% from the prior year.
• Goodwill fell to $7.9 million in Q1 2026 per ANIK's latest filing, from $8.1 million in the prior quarter.
• Over five years, Goodwill peaked at $8.1 million in Q2 2025 and troughed at $6.7 million in Q3 2022.
• A 5-year average of $7.5 million and a median of $7.5 million in 2023 frame the typical range for Goodwill.
• The sharpest annual moves came in 2022 and 2025: Goodwill decreased 15.46% in 2022, then climbed 13.04% in 2025.
• A 5-year view of Goodwill shows it stood at $7.3 million in 2022, then gained by 3.16% to $7.6 million in 2023, then retreated by 5.89% to $7.1 million in 2024, then advanced by 13.04% to $8.1 million in 2025, then dropped by 2.01% to $7.9 million in 2026.
• Business Quant data shows ANIK's Goodwill at $7.9 million in Q1 2026, $8.1 million in Q4 2025, and $8.1 million in Q3 2025.